// App-Quantinova.ai

1258 : Therapeutic potential of the cyclin- dependent kinase inhibitor on c-Myc overexpressing esophageal adenocarcinoma

Researchers

Presenter

  • Sazzad Hassan

Principal Investigators

  • Niranjan Awasthi

  • Margaret A. Schwarz

  • Roderich E. Schwarz

  • Urs V. Holzen

Medical Centers

  • Indiana University School of Medicine South Bend, South Bend, IN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Esophageal Cancer

  • Peritoneal cancer

  • Solid malignancies

Biomarkers

  • cMYC

Drug/Treatment

  • Alvocidib hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved